These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 9669057

  • 21. A 6-week double-blind comparison of amlodipine and placebo in patients with stable exertional angina pectoris receiving concomitant beta-blocker therapy.
    Klein W, Mitrovic V, Neuss H, Schlepper M, Cocco G, Prager G, Fitscha P, Meisner W.
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S50-2. PubMed ID: 16296710
    [Abstract] [Full Text] [Related]

  • 22. Mibefradil, a pharmacologically distinct calcium antagonist.
    Ernst ME, Kelly MW.
    Pharmacotherapy; 1998; 18(3):463-85. PubMed ID: 9620098
    [Abstract] [Full Text] [Related]

  • 23. Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study.
    Sellier P, Broustet JP.
    Am J Cardiovasc Drugs; 2003; 3(5):361-9. PubMed ID: 14728070
    [Abstract] [Full Text] [Related]

  • 24. Antianginal efficacy over 24 hours and exercise hemodynamic effects of once daily sustained-release 300 mg diltiazem and 240 mg verapamil in stable angina pectoris.
    De Rosa ML, Giordano A, Melfi M, Della Guardia D, Ciaburri F, Rengo F.
    Int J Cardiol; 1998 Jan 05; 63(1):27-35. PubMed ID: 9482142
    [Abstract] [Full Text] [Related]

  • 25. Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study Group.
    Heller GV, Sridharan M, Morse J, Glasser S, Beach CL.
    Pharmacotherapy; 1997 Jan 05; 17(4):760-6. PubMed ID: 9250554
    [Abstract] [Full Text] [Related]

  • 26. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
    Ruzyllo W, Tendera M, Ford I, Fox KM.
    Drugs; 2007 Jan 05; 67(3):393-405. PubMed ID: 17335297
    [Abstract] [Full Text] [Related]

  • 27. Antianginal and anti-ischemic efficacy of nisoldipine in stable angina pectoris: a randomized, double-blind, placebo-controlled trial.
    Chen YH, Liu RC, Wang SP.
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov 05; 58(5):323-8. PubMed ID: 9037847
    [Abstract] [Full Text] [Related]

  • 28. Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: potential role of rebound ischemia during the nitrate-free period.
    Freedman SB, Daxini BV, Noyce D, Kelly DT.
    J Am Coll Cardiol; 1995 Feb 05; 25(2):349-55. PubMed ID: 7829787
    [Abstract] [Full Text] [Related]

  • 29. Dipyridamole in chronic stable angina pectoris; a randomized, double blind, placebo-controlled, parallel group study.
    Picano E, PISA (Persantin In Stable Angina) study group.
    Eur Heart J; 2001 Oct 05; 22(19):1785-93. PubMed ID: 11549300
    [Abstract] [Full Text] [Related]

  • 30. Mibefradil: a new class of calcium-channel antagonists.
    Billups SJ, Carter BL.
    Ann Pharmacother; 1998 Jun 05; 32(6):659-71. PubMed ID: 9640486
    [Abstract] [Full Text] [Related]

  • 31. Antihypertensive effects of mibefradil in the treatment of mild-to-moderate systemic hypertension.
    Oparil S, Bernink P, Bursztyn M, Carney S, Kobrin I.
    Am J Cardiol; 1997 Aug 21; 80(4B):12C-19C. PubMed ID: 9286849
    [Abstract] [Full Text] [Related]

  • 32. Amlodipine combined with beta blockade for chronic angina: results of a multicenter, placebo-controlled, randomized double-blind study.
    DiBianco R, Schoomaker FW, Singh JB, Awan NA, Bennett T, Canosa FL, Kawanishi DT, Bamrah VS, Glasser SP, Barry W.
    Clin Cardiol; 1992 Jul 21; 15(7):519-24. PubMed ID: 1354085
    [Abstract] [Full Text] [Related]

  • 33. Randomized comparison of T-type versus L-type calcium-channel blockade on exercise duration in stable angina: results of the Posicor Reduction of Ischemia During Exercise (PRIDE) trial.
    Lee DS, Goodman S, Dean DM, Lenis J, Ma P, Gervais PB, Langer A, PRIDE Investigators.
    Am Heart J; 2002 Jul 21; 144(1):60-7. PubMed ID: 12094189
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
    Witkowska M, Tracz W, Kubler G, Negrusz-Kawecka M, Hlawaty M, Olszowska M, Salamon P.
    Przegl Lek; 1997 Jul 21; 54(5):324-8. PubMed ID: 9380807
    [Abstract] [Full Text] [Related]

  • 36. Comparative efficacy and tolerability of two long-acting calcium antagonists, mibefradil and amlodipine, in essential hypertension. Mibefradil Hypertension Study Group.
    Karch FE, Pordy R, Benz JR, Carr A, Lunde NM, Marbury T, Tarro JN.
    Clin Ther; 1997 Jul 21; 19(6):1368-78. PubMed ID: 9444446
    [Abstract] [Full Text] [Related]

  • 37. Dose-response characteristics of mibefradil, a novel calcium antagonist, in the treatment of essential hypertension.
    Oparil S, Kobrin I, Abernethy DR, Levine BS, Reif MC, Shepherd AM.
    Am J Hypertens; 1997 Jul 21; 10(7 Pt 1):735-42. PubMed ID: 9234827
    [Abstract] [Full Text] [Related]

  • 38. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
    Thadani U, Ezekowitz M, Fenney L, Chiang YK.
    Circulation; 1994 Aug 21; 90(2):726-34. PubMed ID: 8044941
    [Abstract] [Full Text] [Related]

  • 39. Antianginal effects of trimetazidine and left ventricular function improvement in patients with stable angina pectoris.
    Shlyakhto EV, Almazov VV, Nifontov EM, Vakhrameyeva IV, Rudomanov OG, Zakharov DV, Kazarin VV, Vakhrameyeva NV.
    Am J Cardiovasc Drugs; 2002 Aug 21; 2(2):119-24. PubMed ID: 14727987
    [Abstract] [Full Text] [Related]

  • 40. [Efficacy and tolerance of trimetazidine, a metabolic antianginal, in combination with a hemodynamic antianginal in stable exertion angina. TRIMPOL I, a multicenter study].
    Szwed H, Pachocki R, Domzal-Bochenska M, Szymczak K, Szydlowski Z, Paradowski A, Gajos G, Kaluza G, Kulon I, Wator-Brzezińska A, Elikowski W, Kuźniak M.
    Presse Med; 2000 Mar 18; 29(10):533-8. PubMed ID: 10761517
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.